Researchers evaluated the efficacy of bisphosphonate risedronate vs alfacalcidol in steroid-induced osteopenia in children.
The study assessed the implications of genetic advances in juvenile idiopathic arthritis; the results of the research may be useful in the treatment of arthritis in children.
The study investigated the outcomes of pregnancies involving patients with JIA exposed to DMARDs.
Multiple stakeholders were brought together to discuss the challenges surrounding trials, and the testing and authorization of new medicines for juvenile idiopathic arthritis.
This study evaluated the frequency of achieving inactive disease in children with JIA treated solely with methotrexate and identified a model for patients with a lesser likelihood of reaching inactive disease with methotrexate.
The study aimed to describe clinical characteristics, risk factors, histopathologic and immunologic features of systemic juvenile idiopathic arthritis-associated lung disease (SJIA-LD).
The study evaluated IL-18 levels in systemic juvenile idiopathic arthritis by assessing disease activity, history of macrophage activation syndrome, and other disease biomarkers.
The study compared pediatric and adult patients with CRMO/CNO and SAPHO syndrome, respectively.
Using whole-body MRI, this study evaluates the efficacy of pamidronate in children with chronic nonbacterial osteitis.
The researchers identified monogenic SLE etiologies to confirm the presence of genetic locus heterogeneity in childhood-onset lupus.